Qian Y. Sun

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia.

Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia.

Journal: Blood and lymphatic cancer : targets and therapy

Published: May 01, 2026

A Systematic Concept Analysis of Psychological Birth Trauma in Couples.

A Systematic Concept Analysis of Psychological Birth Trauma in Couples.

Journal: International journal of women's health

Published: February 25, 2026

Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis.

Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis.

Journal: BMC medicine

Published: February 07, 2026

Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.

Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.

Journal: Blood

Published: February 03, 2026

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study.

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study.

Journal: Frontiers in oncology

Published: December 10, 2025

Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling.

Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling.

Journal: Journal of orthopaedic translation

Published: November 13, 2025

Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study.

Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study.

Journal: Annals of hematology

Published: September 06, 2025

What do we know about midwife-woman interactions during vaginal childbirth: a scoping review and thematic analysis.

What do we know about midwife-woman interactions during vaginal childbirth: a scoping review and thematic analysis.

Journal: BMC pregnancy and childbirth

Published: April 24, 2025

Identifying an immunogenic cell death-related gene signature and HSPA6 infers adverse prognosis in acute myeloid leukemia.

Identifying an immunogenic cell death-related gene signature and HSPA6 infers adverse prognosis in acute myeloid leukemia.

Journal: Journal of Cancer

Published: April 14, 2025

Acute Myeloid Leukemia Patients with High-Risk Karyotypes Benefit from Decitabine in Combination with Modified CAG.

Acute Myeloid Leukemia Patients with High-Risk Karyotypes Benefit from Decitabine in Combination with Modified CAG.

Journal: Biochemical genetics

Published: February 26, 2025

Comparative efficacy of closed reduction versus open reduction with pelvic osteotomy for developmental dysplasia of the hip in children aged 18-24 months: A retrospective cohort study.

Comparative efficacy of closed reduction versus open reduction with pelvic osteotomy for developmental dysplasia of the hip in children aged 18-24 months: A retrospective cohort study.

Journal: PloS one

Published: February 03, 2025

Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis.

Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis.

Journal: Oncology research

Published: January 15, 2025

Showing 1-12 of 75

Last Updated: 09/26/2026